chr1-207485526-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001006658.3(CR2):c.3251C>A(p.Ser1084Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,612,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001006658.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CR2 | NM_001006658.3 | c.3251C>A | p.Ser1084Tyr | missense_variant | 19/20 | ENST00000367057.8 | NP_001006659.1 | |
CR2 | NM_001877.5 | c.3074C>A | p.Ser1025Tyr | missense_variant | 18/19 | NP_001868.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CR2 | ENST00000367057.8 | c.3251C>A | p.Ser1084Tyr | missense_variant | 19/20 | 1 | NM_001006658.3 | ENSP00000356024 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152198Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000797 AC: 20AN: 250850Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135774
GnomAD4 exome AF: 0.0000329 AC: 48AN: 1460564Hom.: 0 Cov.: 29 AF XY: 0.0000275 AC XY: 20AN XY: 726694
GnomAD4 genome AF: 0.000361 AC: 55AN: 152198Hom.: 0 Cov.: 31 AF XY: 0.000282 AC XY: 21AN XY: 74354
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 7 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 19, 2022 | This sequence change replaces serine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 1084 of the CR2 protein (p.Ser1084Tyr). This variant is present in population databases (rs142273168, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with CR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 473100). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.3251C>A (p.S1084Y) alteration is located in exon 19 (coding exon 19) of the CR2 gene. This alteration results from a C to A substitution at nucleotide position 3251, causing the serine (S) at amino acid position 1084 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at